Vultaggio, Alessandra

Impaired immune cell cytotoxicity in severe COVID-19 is IL-6 dependent

Mazzoni, A., Salvati, L., Maggi, L., Capone, M., Vanni, A., Spinicci, M., Mencarini, J., Caporale, R., Peruzzi, B., Antonelli, A., et al. (2020) · Journal of Clinical Investigation

COVID-19 Clinical Research StudiesSARS-CoV-2 and COVID-19 Research

Cited by 502

Subcutaneous Immunoglobulin Replacement Therapy in Patients with Primary Immunodeficiency in Routine Clinical Practice: The VISPO Prospective Multicenter Study

Vultaggio, A., Azzari, C., Milito, C., Finocchi, A., Toppino, C., Spadaro, G., Trizzino, A., Baldassarre, M., Paganelli, R., Moschese, V., et al. (2015) · Clinical Drug Investigation

Immunodeficiency and Autoimmune DisordersNeutropenia and Cancer Infections

Cited by 58

Response to biologic drugs in patients with rheumatoid arthritis and antidrug antibodies

Bitoun, S., Hässler, S., Ternant, D., Szely, N., Gleizes, A., Richez, C., Soubrier, M., Avouac, J., Brocq, O., Sellam, J., et al. (2023) · JAMA Network Open

Rheumatoid Arthritis Research and TherapiesBiosimilars and Bioanalytical Methods

Cited by 43